RevitaDERM Wound Care
RevitaDERM Wound Care is an FDA drug label for the active ingredient BENZALKONIUM CHLORIDE manufactured by Blaine Labs Inc. administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231221.
Generic: BENZALKONIUM CHLORIDE
Manufacturer: Blaine Labs Inc.
Product Type: HUMAN OTC DRUG
Route: TOPICAL
Dosage Form:
NDC: 63347-120
Application: M003
Effective: 20231221
Active Ingredients: Active Ingredients Active Ingredients Benzalkonium Chloride (0.1%)
Indications & Usage
Uses Uses * 1st and 2nd Degree Burns * Stasis Ulcers * Pressure Ulcers * Diabetic Ulcers * Lacerations * Abrasions * Skin Tears * Surgical Incision Sites * Device Insertion Sites * Graft Sites * Donor Sites
Dosage & Administration
Directions Directions Evenly apply RevitaDERM Wound Care approximately 1/8 inch to 1/4 inch thick to the wound area. Cover wound with appropriate dressing. Repeat as necessary to keep the wound moist.
Contraindications
Not available.
Warnings
Warnings Warnings For external use only.
Adverse Reactions
Not available.
More from same ingredient
Alcohol Free Hand Sanitizer
FULLER INDUSTRIES, INC
Antibacterial Hand Cleanser
Kutol Products Company
Antibacterial Wet Wipes
Zhejiang Ayan Biotech Co.,Ltd.
Antibacterial Wet Wipes
HangZhou YangYi Daily Cosmetics Technology Co., Ltd.
Antibacterial Wipes
SHAOXING ELITE BIO-TECH CO.,LTD.
Antiseptic BZK Towelette
Cardinal Health 200, Inc.
BZK
Jianerkang Medical Co., Ltd
BZK Antiseptic Towelette Non-Sterile
Jianerkang Medical Co., Ltd